Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease.

J Transl Med

Department of Infectious Disease, The People's Hospital of Yubei District of Chongqing City, No.23, North Central Park Road, Yubei District, Chongqing, 401120, China.

Published: February 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900530PMC
http://dx.doi.org/10.1186/s12967-023-03965-3DOI Listing

Publication Analysis

Top Keywords

bi-anti therapy
4
therapy sars-cov-2
4
sars-cov-2 infection
4
infection mild/moderate
4
mild/moderate patients
4
patients prevent
4
prevent coronavirus
4
coronavirus disease
4
disease 2019
4
2019 progressing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!